If you were born before 2015 in the UK, you are almost certainly unvaccinated against meningitis B — the most common cause of bacterial meningitis in this country and the strain responsible for the 2026 Kent outbreak. The NHS only began routinely vaccinating infants against MenB in September 2015, and the MenACWY vaccine offered to teenagers at school does not cover MenB. Whether you need the vaccine depends on your age, vaccination history, lifestyle, medical conditions, and risk factors. This guide will help you make an informed decision.

Subscribe now

The Quick Risk Assessment

Ask yourself these questions to determine whether you should consider MenB vaccination.

Were you born before May 2015? If yes, you are very unlikely to have been vaccinated against MenB on the NHS. This applies to virtually every current teenager (born before 2015), university student, and adult in the UK.

Have you ever been vaccinated against MenB privately? If you are unsure, check your vaccination records (red book, GP records, or travel vaccination booklet). If there is no record of Bexsero vaccination, you are unprotected.

Are you or your child a university student or about to start university? Students face one of the highest risks due to shared accommodation, crowded socialising, and close contact with large numbers of new people.

Do you live in shared accommodation? Halls of residence, house-shares, military barracks, and other communal living environments increase transmission risk.

Do you have a medical condition that increases risk? Asplenia, sickle cell disease, complement disorders, or immunosuppression all significantly elevate risk.

Are you travelling to a high-risk region? Parts of sub-Saharan Africa (the “meningitis belt”) have much higher meningococcal disease rates.

If you answered “yes” to the first question and any of the others, vaccination is strongly worth considering. Even if your only risk factor is being unvaccinated, the devastating nature of meningococcal disease — 8–15% case fatality, up to 20% of survivors with permanent disability — makes this a proportionate investment in protection.

Who Is at Highest Risk

Meningococcal disease does not affect all age groups equally. Understanding the risk distribution helps you assess where you sit.

Infants under 1 year face the highest incidence of all age groups. This is why the NHS prioritised babies for the routine MenB vaccination programme. Infants born since 2015 who have completed their vaccination schedule are well protected.

Adolescents and young adults aged 15–24 have the second-highest incidence. This age group also has the highest carriage rates — between 10% and 25% of teenagers carry meningococcal bacteria in their throat without symptoms, compared to 3–10% of the general adult population. The bacteria are spread through close contact, kissing, sharing drinks and vapes, and living in close proximity.

University freshers face a particularly acute risk in their first term. The sudden exposure to large numbers of new people from different regions, combined with the social behaviours of student life (shared living, nightlife, close contact), creates ideal conditions for transmission. The 2026 Kent outbreak is a textbook illustration of this vulnerability.

People with specific medical conditions face elevated risk regardless of age. These include individuals with no spleen or a non-functioning spleen (asplenia/hyposplenia), sickle cell disease, complement deficiency disorders, those on complement inhibitor treatment (such as eculizumab), coeliac disease, and certain immunodeficiency conditions. These individuals are eligible for free NHS MenB vaccination — speak to your GP if you have any of these conditions and have not been vaccinated.

Healthcare workers who may be exposed to meningococcal patients or work in microbiology laboratories handling Neisseria meningitidis are also at elevated risk.

Travellers to endemic regions — particularly the African meningitis belt (from Senegal to Ethiopia) — should discuss meningococcal vaccination with a travel health specialist.

The Common Misconception: “I Had the Meningitis Vaccine at School”

This is the single most widespread misconception we encounter, and it is critically important to understand.

The vaccine offered to teenagers in UK schools at approximately age 14 is the MenACWY vaccine. It protects against meningococcal groups A, C, W, and Y. It does not protect against group B.

The MenB vaccine (Bexsero) is a completely separate vaccine. It was only introduced into the NHS routine schedule in 2015 for infants. No catch-up programme has been offered for teenagers or adults (though the Health Secretary asked the JCVI to re-examine this in March 2026 following the Kent outbreak).

Having the MenACWY vaccine provides absolutely zero protection against MenB. If you received the school vaccine and nothing else, you are protected against four strains but completely unprotected against the most common cause of bacterial meningitis in the UK.

Both vaccines can be given at the same appointment if needed. There is no interaction between them.

The Numbers Behind the Decision

Making a vaccination decision means weighing the probability and severity of the disease against the cost and inconvenience of vaccination.

Probability: Meningococcal disease is rare. In 2024–25, 378 cases were confirmed in the UK, with 31 deaths. Your absolute risk of contracting the disease in any given year is low. However, the 2026 Kent outbreak — 20 cases in under a week, including 2 deaths — demonstrates that the disease can cluster rapidly in vulnerable populations.

Severity: When meningococcal disease does occur, the consequences are severe. The case fatality rate is 8–15% — roughly one in ten to one in seven. Among survivors, up to 20% suffer permanent disabilities including brain damage, hearing loss, limb amputations, kidney failure, and extensive scarring. The disease can progress from first symptoms to death within 24 hours.

Vaccine effectiveness: Bexsero protects against approximately 88% of MenB strains circulating in the UK. The NHS childhood programme demonstrated a 75% reduction in invasive MenB disease among vaccinated infants over three years (EMA, 2025).

Cost: At The Online GP by The Wellness, MenB vaccination starts from £495 per dose (full course from £990), reflecting current shortage-related sourcing costs. This is a significant but proportionate investment when measured against the potential consequences of unprotected exposure.

Risk equation: A rare disease with catastrophic consequences, against which an effective vaccine exists, and for which you are likely unprotected. This is the calculation each individual and family must make.

Special Circumstances

Pregnant women: The safety of Bexsero in pregnancy has not been fully established. Current guidance recommends vaccination during pregnancy only if there is a clear risk of exposure. Discuss this with your doctor.

Breastfeeding mothers: Limited data are available, but no safety concerns have been identified. The benefit-risk ratio should be discussed with your doctor.

People with egg allergies: Bexsero does not contain egg and is safe for people with egg allergies.

People who have had meningitis before: Previous meningococcal disease does not necessarily provide complete immunity, and you may not have had the MenB strain. Vaccination is still recommended.

Immunosuppressed individuals: Those on immunosuppressive medication may have a reduced immune response to the vaccine but should still be vaccinated. Your doctor will advise on the optimal approach.

How to Access Private MenB Vaccination

The Online GP by The Wellness offers doctor-led private MenB vaccination from our Marylebone clinic. Due to the national shortage following the March 2026 Kent outbreak, we are currently operating a waiting list. Here is how to proceed.

Contact us on WhatsApp at +44 7961 280835 or email team@thewellnesslondon.com to register your interest. We will add you to our priority notification list. When stock becomes available, we will contact you to arrange your appointment. Pricing starts from £495 per dose (full two-dose course from £990), which includes a comprehensive doctor consultation, the Bexsero vaccine, administration, and post-vaccination monitoring.

While waiting for MenB stock, consider whether you also need any other vaccinations. We offer the full range of travel and general vaccines, many of which are available immediately. Our doctors can review your complete vaccination history and identify any gaps.

We also offer same-day GP appointments from £49 for any health concern, blood testing, ultrasound scans (from £175with same-day results), and our Executive Body Scan at £695.

Register for MenB Waiting List — WhatsApp →

Book a Vaccination Review — WhatsApp →

Same-Day GP Appointment — WhatsApp →

Or email team@thewellnesslondon.com

Frequently Asked Questions

Do adults need the meningitis B vaccine?

Most UK adults are unvaccinated against MenB and should consider vaccination, particularly university students, young adults, people in shared accommodation, healthcare workers, and travellers to endemic regions.

Is my child vaccinated against MenB?

Only if born on or after 1 May 2015 and received their NHS immunisations. The MenACWY school vaccine does NOT cover MenB.

I am over 25 — should I get vaccinated?

Bexsero has no upper age limit in the UK. If you have risk factors (shared accommodation, healthcare work, travel, medical conditions), vaccination is worth considering. Discuss with a doctor.

Do I need MenB if I had MenACWY?

Yes. These are completely different vaccines covering different strains. MenACWY provides zero protection against MenB.

Is meningitis common enough to justify vaccination?

It is rare (378 UK cases in 2024–25) but devastating when it occurs — 8–15% fatal, 20% of survivors with permanent disability. The Kent outbreak showed it can strike rapidly. Vaccination is a proportionate response.

Should I get vaccinated even without a link to Kent?

Yes, if you are in a higher-risk group. Meningococcal disease occurs across the UK year-round. The Kent outbreak raised awareness, but the underlying risk exists independently.

How do I get vaccinated privately?

Contact The Online GP by The Wellness on WhatsApp (+44 7961 280835) or email team@thewellnesslondon.com. MenB is currently on a waiting list. MenACWY and other vaccines may be available immediately.

The Online GP by The Wellness provides private doctor-led healthcare from our Marylebone clinic. Contact us on WhatsApp at +44 7961 280835 or email team@thewellnesslondon.com.

If you suspect meningitis symptoms, call 999 or go to A&E immediately.